Published in J Drugs Dermatol on October 01, 2007
Human growth factor cream and hyaluronic Acid serum in conjunction with micro laser peel: an efficient regimen for skin rejuvenation. J Clin Aesthet Dermatol (2010) 0.75
Skin rejuvenation using cosmetic products containing growth factors, cytokines, and matrikines: a review of the literature. Clin Cosmet Investig Dermatol (2016) 0.75
Full scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg (2006) 2.01
Histologic evaluation of interstitial lipolysis comparing a 1064, 1320 and 2100 nm laser in an ex vivo model. Lasers Surg Med (2008) 1.73
Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid. Dermatol Surg (2006) 1.63
Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration. Dermatol Surg (2005) 1.48
Mycobacterium chelonae infection after fractionated carbon dioxide facial resurfacing (presenting as an atypical acneiform eruption): case report and literature review. Dermatol Surg (2010) 1.48
Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol (2008) 1.45
An investigation into the influence of various gases and concentrations of sclerosants on foam stability. Dermatol Surg (2010) 1.41
Abbreviations for device names: a proposed methodology with specific examples. Dermatol Surg (2013) 1.40
Randomized Split-Face Study to Assess the Efficacy and Safety of AbobotulinumtoxinA Versus OnabotulinumtoxinA in the Treatment of Melomental Folds (Depressor Anguli Oris). Dermatol Surg (2015) 1.38
Efficacy of a novel combination of pneumatic energy and broadband light for the treatment of acne. J Drugs Dermatol (2008) 1.08
5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg (2004) 1.03
The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol (2006) 1.03
A single center, randomized, comparative, prospective clinical study to determine the efficacy of the VelaSmooth system versus the Triactive system for the treatment of cellulite. Lasers Surg Med (2006) 1.01
Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol (2007) 1.00
Analysis of incidence of bulla formation after tattoo treatment using the combination of the picosecond Alexandrite laser and fractionated CO2 ablation. Dermatol Surg (2015) 0.97
The adverse events of deep fractional CO(2): a retrospective study of 490 treatments in 374 patients. Lasers Surg Med (2011) 0.96
Laser lipolysis: current practices. Semin Cutan Med Surg (2009) 0.95
Adverse events of fractionated carbon dioxide laser: review of 373 treatments. Dermatol Surg (2010) 0.95
Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: hylaform versus restylane. Dermatol Surg (2005) 0.90
Hand rejuvenation: a review and our experience. Dermatol Surg (2012) 0.90
Facial resurfacing in patients with Fitzpatrick skin type IV. Lasers Surg Med (2002) 0.89
Retrospective evaluation of micro-focused ultrasound for lifting and tightening the face and neck. Dermatol Surg (2014) 0.89
Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. J Drugs Dermatol (2009) 0.89
Laser and sclerotherapy treatment of leg veins: my perspective on treatment outcomes. Dermatol Surg (2002) 0.87
Autologous fat transfer: an in-depth look at varying concepts and techniques. Facial Plast Surg Clin North Am (2007) 0.87
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment. J Drugs Dermatol (2009) 0.86
Prospective, comparative evaluation of three laser systems used individually and in combination for axillary hair removal. Dermatol Surg (2005) 0.86
Histologic and clinical response to varying density settings with a fractionally scanned carbon dioxide laser. J Drugs Dermatol (2009) 0.86
Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg (2002) 0.86
Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol (2004) 0.85
Comparative evaluation of long-pulse alexandrite and long-pulse Nd:YAG laser systems used individually and in combination for axillary hair removal. Dermatol Surg (2008) 0.85
Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg (2003) 0.84
Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J Drugs Dermatol (2008) 0.84
A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy. J Drugs Dermatol (2006) 0.84
The safety and effectiveness of single-pass erbium:YAG laser in the treatment of mild to moderate photodamage. Dermatol Surg (2004) 0.84
Evaluation of microfocused ultrasound with visualization for lifting, tightening, and wrinkle reduction of the décolletage. J Am Acad Dermatol (2013) 0.83
Sublative rejuvenation: experience with a new fractional radiofrequency system for skin rejuvenation and repair. J Drugs Dermatol (2009) 0.83
Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid. J Drugs Dermatol (2006) 0.83
The effects of filtrate of the secretion of the <EM>Cryptomphalus aspersa</EM> on photoaged skin. J Drugs Dermatol (2013) 0.82
Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique. Dermatol Surg (2005) 0.82
Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg (2012) 0.82
Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. J Drugs Dermatol (2007) 0.82
A comparison of three separate clinical studies evaluating the safety and efficacy of laser-assisted lipolysis using 1,064, 1,320 nm, and a combined 1,064/1,320 nm multiplex device. Lasers Surg Med (2009) 0.81
A prospective multicenter pilot study of the safety and efficacy of microfocused ultrasound with visualization for improving lines and wrinkles of the décolleté. Dermatol Surg (2015) 0.81
Safety and efficacy comparison of blue versus red light sources for photodynamic therapy using methyl aminolevulinate in photodamaged skin. J Drugs Dermatol (2011) 0.81
Rejuvenation of the aging chest: a review and our experience. Dermatol Surg (2011) 0.81
Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser. J Cosmet Dermatol (2007) 0.80
Efficacy of hydroquinone-free skin-lightening cream for photoaging. J Cosmet Dermatol (2013) 0.80
Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatments. Dermatol Surg (2015) 0.80
Clinical Efficacy of Self-applied Blue Light Therapy for Mild-to-Moderate Facial Acne. J Clin Aesthet Dermatol (2009) 0.80
A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Drugs Dermatol (2005) 0.80
Novel hyaluronic acid dermal filler: dermal gel extra physical properties and clinical outcomes. Dermatol Surg (2010) 0.80
A double-blinded randomized trial testing the tolerability and efficacy of a novel topical agent with and without occlusion for the treatment of cellulite: a study and review of the literature. J Drugs Dermatol (2004) 0.80
Fractional Q-switched 1,064-nm laser for the treatment of photoaged-photodamaged skin. J Cosmet Laser Ther (2013) 0.80
Review of intravascular approaches to the treatment of varicose veins. Dermatol Surg (2007) 0.79
Combination of intense pulsed light, Sculptra, and Ultherapy for treatment of the aging face. J Cosmet Dermatol (2014) 0.79
The effect of botulinum toxin type A on full-face intense pulsed light treatment: a randomized, double-blind, split-face study. Dermatol Surg (2008) 0.79
Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg (2004) 0.79
Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg (2005) 0.79
Comparison of pre- and/or postphotodynamic therapy and intense pulsed light treatment protocols for the reduction of postprocedure-associated symptoms and enhancement of therapeutic efficacy. J Drugs Dermatol (2007) 0.79
Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging. J Drugs Dermatol (2012) 0.79
Endoluminal laser delivery mode and wavelength effects on varicose veins in an ex vivo model. Lasers Surg Med (2013) 0.79
Application of intense pulsed light in the treatment of dermatologic disease: a systematic review. Dermatol Surg (2014) 0.79
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol (2004) 0.78
Comparison of two techniques using hyaluronic acid to correct the tear trough deformity. J Drugs Dermatol (2012) 0.78
Regarding "Deep vein thrombosis after radiofrequency ablation of greater saphenous vein: a word of caution". J Vasc Surg (2005) 0.78
Treatment of wrinkles and elastosis using vacuum-assisted bipolar radiofrequency heating of the dermis. Dermatol Surg (2007) 0.78
Patient satisfaction and duration of effect with PLLA: a review of the literature. J Drugs Dermatol (2009) 0.78
Efficacy and safety of and patient satisfaction with injectable hyaluronic acid with 0.3% lidocaine hydrochloride for the treatment of superficial perioral lines or superficial lateral canthal lines. Dermatol Surg (2013) 0.78
Minimizing bruising following fillers and other cosmetic injectables. J Clin Aesthet Dermatol (2013) 0.78
A two-center, double-blinded, randomized trial testing the tolerability and efficacy of a novel therapeutic agent for cellulite reduction. J Cosmet Dermatol (2005) 0.78
Use of light-emitting diode photomodulation to reduce erythema and discomfort after intense pulsed light treatment of photodamage. J Cosmet Dermatol (2008) 0.78
Cosmetic use of poly-l-lactic acid: a retrospective study of 130 patients. Dermatol Surg (2009) 0.78
Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg (2010) 0.78
A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Lasers Surg Med (2014) 0.78
Photodynamic Therapy: A Clinical Consensus Guide. Dermatol Surg (2016) 0.77
A two-center, open-label, randomized, split-face study to assess the efficacy and safety of one versus three intradermal injection sites of abobotulinumtoxinA in the treatment of lateral periocular rhytides. J Drugs Dermatol (2013) 0.77
Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. Dermatol Surg (2008) 0.77
The safety and efficacy of combining poly-L-lactic acid with intense pulsed light in facial rejuvenation: a retrospective study of 90 patients. Dermatol Surg (2012) 0.77
Microfoam ultrasound-guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg (2004) 0.77
Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging. J Drugs Dermatol (2013) 0.77
The Fabi-Bolton chest wrinkle scale: a pilot validation study. J Cosmet Dermatol (2012) 0.77
Ablative CO2 lasers for skin tightening: traditional versus fractional. Dermatol Surg (2014) 0.77
Laser, light, and energy devices for cellulite and lipodystrophy. Clin Plast Surg (2011) 0.76
An evaluation of the patient population for aesthetic treatments targeting abdominal subcutaneous adipose tissue. J Cosmet Dermatol (2014) 0.76
Use of micro-focused ultrasound with visualization to lift and tighten lax knee skin (1.). J Cosmet Laser Ther (2014) 0.76
A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides. Dermatol Surg (2011) 0.76
Safety and efficacy of administering abobotulinumtoxinA through a single injection point when treating lateral periocular rhytides. J Cosmet Dermatol (2011) 0.75
Regarding "Ultrasound findings after radiofrequency ablation of the great saphenous vein". J Vasc Surg (2005) 0.75
Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma. J Cosmet Dermatol (2011) 0.75
Dermatoses of pregnancy. J Am Acad Dermatol (2003) 0.75
Treatment of melasma and the use of intense pulsed light: a review. J Drugs Dermatol (2012) 0.75
Human growth factor cream and hyaluronic Acid serum in conjunction with micro laser peel: an efficient regimen for skin rejuvenation. J Clin Aesthet Dermatol (2010) 0.75
Nomenclature proposal on laser ablation and nonablation. J Am Acad Dermatol (2012) 0.75
Self-diagnosis of Mild-to-Moderate Acne for Self Treatment with Blue Light Therapy. J Clin Aesthet Dermatol (2009) 0.75
Multiple sequential light and laser sources to activate aminolevulinic acid in the treatment of photodamage: A retrospective study. J Cosmet Laser Ther (2015) 0.75
Aminolevulinic acid-photodynamic therapy for photorejuvenation. Dermatol Clin (2007) 0.75
Evaluating the efficacy in improving facial photodamage with a mixture of topical antioxidants. J Drugs Dermatol (2007) 0.75